Table 2 of
Tian, Mol Vis 2020; 26:1-13. Table 2 of
Tian, Mol Vis 2020; 26:1-13.
Table 2. The pathways enriched for the mRNAs implicated in the competing endogenous RNA (ceRNA) regulatory network.
| Term | Count | P-value | Genes |
|---|---|---|---|
| hsa04510:Focal adhesion | 5 | 0.001561 | COL4A2, COL4A1, CCND2, TNC, KDR |
| hsa04060:Cytokine-cytokine receptor interaction | 5 | 0.003707 | CXCL1, CCL22, CXCL5, KDR, CXCL10 |
| hsa04062:Chemokine signaling pathway | 4 | 0.006217 | CXCL1, CCL22, CXCL5, CXCL10 |
| hsa04512:ECM-receptor interaction | 3 | 0.006331 | COL4A2, COL4A1, TNC |
| *hsa04940:Type I diabetes mellitus | 2 | 0.018766 | CPE, HLA-B |
| *hsa05200:Pathways in cancer | 4 | 0.021608 | COL4A2, COL4A1, PPARG, RUNX1T1 |
| hsa04623:Cytosolic DNA-sensing pathway | 2 | 0.023854 | IL33, CXCL10 |
| hsa04270:Vascular smooth muscle contraction | 2 | 0.042772 | EDNRA, PRKG1 |